<DOC>
	<DOCNO>NCT01168505</DOCNO>
	<brief_summary>Study evaluate efficacy intravenous iron supplementation prevention anemia patient receive ( neo ) adjuvant breast cancer regimen .</brief_summary>
	<brief_title>Iron Supplement Prevention Anemia Female Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>1 . Women old 18 year 2 . Patient operate breast cancer indication ( NEO ) adjuvant therapy 3 . They must hemoglobin level within normal range ( &gt; 12g/dL ) , absence renal hepatic dysfunction assess serum level urea , creatinine , AST , ALT . 4 . Lack folic acid deficiency vitamin B12 5 . Able provide write informed consent . 1 . Use oral supplement contain iron ; 2 . Patients iron overload define serum ferritin &gt; 800 microg / L transferrin saturation &gt; 40 % ; 3 . Patients pregnant breastfeeding ; 4 . History active infection active bleeding except menstruation ; 5 . History HIV hepatitis B C clinically important ;</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>